Rebus Biosystems
Santa Clara
About Rebus Biosystems
Rebus Biosystems is a venture-backed Silicon Valley-based life science technology company creating revolutionary tools to enable spatial omics research without compromise. The company’s first instrument, the Rebus Esper, is a fully integrated, automated spatial omics platform that delivers quantitative single molecule, single-cell data with subcellular resolution. Advanced imaging, on-system chemistry, and intuitive software have been combined to provide an end-to-end solution requiring minimal hands-on time. Rebus Biosystems provides all-inclusive assay kits to empower researchers with the resolution, scale and speed of the Rebus Esper for multiple applications. Learn more at www.rebusbio.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $37.8M
- Last round: Series Unknown (Nov 2022)
- Website: rebusbio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/rebus-biosystems-17979 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.